Moleculin Biotech, Inc. Derivative Liability, Current
Moleculin Biotech, Inc. (MBRX) had Derivative Liability, Current of $0 as of 2019-12-31, per its 10-K filed 2020-03-19.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2020-03-19
- 2019-12-31: Derivative Liability, Current $0.00.
- 2019-09-30: Derivative Liability, Current $6.82M.
- 2019-06-30: Derivative Liability, Current $6.94M.
- 2019-03-31: Derivative Liability, Current $2.39M.
| Period end | Derivative Liability, Current |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-19 |
| 2019-09-30 | $6.82M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $6.94M 10-Q · filed 2019-08-16 |
| 2019-03-31 | $2.39M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $180.00K 10-K · filed 2020-03-19 |
| 2018-09-30 | $369.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $451.00K 10-Q · filed 2018-08-10 |
| 2018-03-31 | $463.00K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $503.00K 10-K · filed 2019-02-21 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |